Pharmacist GI | New Drugs | Pediatrics Podcast 45 credit minutes

Pediatric irritable bowel syndrome with constipation (IBS-C) can significantly affect quality of life and presents unique treatment and counseling challenges for patients and families. This course reviews evolving management strategies for pediatric IBS-C, including newly approved treatment options and practical considerations for therapy selection. You will be better prepared to evaluate treatment approaches and counsel families on the safe and appropriate use of therapy for pediatric IBS-C. 

Available in Subscription

This course is included in the following subscription:

Pharmacist CE Subscription

Pharmacist CE Subscription

Renewed Annually
$99.00 / year

Learning Objectives

1. Describe current treatment considerations for pediatric IBS-C, including recently approved pharmacologic options.
2. Compare factors that influence treatment selection and family counseling for pediatric IBS-C. 

Faculty

Rachel Maynard, PharmD

Disclosures:

Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.

Christopher Hartley, PharmD, BCPPS

Disclosures:

Christopher Hartley has no relevant financial relationships with ineligible companies to disclose.

Course Details